USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Global Pharmaceutical Industry Outlook, 2023
Transformative Megatrends are Expanding the Vendor Ecosystem
27-Mar-2023
Global
Market Outlook
PE5D-01-00-00-00
HC03649-GL-MO_27529
$4,950.00
Special Price $3,712.50 save 25 %
This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the Asia-Pacific, Latin America, and the Rest of the World. Inflation will continue to be a pressing challenge for the pharmaceutical industry in 2023, affecting returns on investment. Pharmaceutical companies will continue to shift towards regional rather than global suppliers to ensure geographic proximity and a smoother, more reliable supply chain. There will be a strong focus on environmental, social, and governance (ESG) commitments and supply-chain digitalization through lighthouse manufacturing techniques, decentralized clinical trial (DCT) approaches, and the application of artificial intelligence (AI). The study segments the pharmaceutical industry into two key segments, namely, chemicals/small molecules and biologics. It covers the following:
• An overview of the pharmaceutical industry
• Revenue forecasts by segment
• Top 5 predictions for the industry for 2023 and beyond
• Key macro and micro trends driving the future of the industry
• Research and development (R&D) expenditure and key therapeutic areas for 2023 and beyond
• Growth opportunities emerging from this space for stakeholders and market players to leverage
Author: Surbhi Gupta
Key Highlights
Top Predictions for 2023
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Global Pharmaceutical Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Segmentation and Scope
Key Trend 1: Adoption of Lighthouse Manufacturing Techniques
Key Trend 1: Adoption of Lighthouse Manufacturing Techniques (continued)
Key Trend 2: Increased Focus on Fulfilling ESG Commitments
Key Trend 2: Increased Focus on Fulfilling ESG Commitments (continued)
Key Trend 3: Increased Application of AI across the Pharma Value Chain
Key Trend 3: Increased Application of AI across the Pharma Value Chain (continued)
Key Trend 4: Intensification of Skilled Workforce Challenges
Key Trend 4: Intensification of Skilled Workforce Challenges (continued)
Global Pharmaceutical Industry: R&D Expenditure Outlook
Global Drug Development Pipeline by Clinical Phase
Key Therapeutic Areas Outlook
Top 5 Global Economic Highlights of 2022
Top 5 Global Economic Highlights of 2023
Global GDP Growth Expectations
Recessionary/Slowdown Expectations for Major Economies
Global GDP Growth Snapshot
Advanced Economy Predictions for 2023
Emerging Market Economy Predictions for 2023
2023 Regional Risks and Policy Direction
2023 Top Growth Opportunities by Region
Right Shoring vs. Reshoring: Impact Analysis
Right Shoring vs. Reshoring: Impact Analysis (continued)
Rising Inflation: Impact Analysis
Rising Inflation: Impact Analysis (continued)
Global Pharmaceutical Industry: Historic Sales and Forecast
Segment Performance: Historic Sales and Forecast
Revenue Forecast by Region
Regulatory Regional Trends: North America
Regulatory Regional Trends: Europe
Regulatory Regional Trends: Asia-Pacific, Latin America, the Middle East and Africa
Prediction 1
Prediction 2
Prediction 3
Prediction 4
Prediction 5
Small Molecules Snapshot, 2023
Small Molecules: Companies to Watch
Biologics Snapshot, 2023
Biologics Snapshot: Companies to Watch
Growth Opportunity 1: Drug and Software-as-a-Medical-Device (SaMD) Combination Products and Platforms
Growth Opportunity 1: Drug and Software-as-a-Medical-Device (SaMD) Combination Products and Platforms (continued)
Growth Opportunity 2: Dual and Multi-targeting Antibodies for Immuno-oncology
Growth Opportunity 2: Dual and Multi-targeting Antibodies for Immuno-oncology (continued)
Growth Opportunity 3: Strategic CGT Partnerships between Academia, CDMOs, and Biopharma Companies in the EU
Growth Opportunity 3: Strategic CGT Partnerships between Academia, CDMOs, and Biopharma Companies in the EU (continued)
Key Conclusions
Market Definition: Pharmaceuticals and Biotechnology
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
List of Figures
- Pharmaceutical Industry: Implication for Key Stakeholders, Global, 2022–2027
- Pharmaceutical Industry: R&D Expenditure Forecast, Global, 2020–2027
- Pharmaceutical Industry: Drug Development Pipeline by Clinical Phase, Global, 2021–2022
- Pharmaceutical Industry: Therapeutic Segment Split, Global, 2022
- Pharmaceutical Industry: Therapeutic Segment Split, Global, 2027
- Comparison of January 2023 and August 2022 Frost & Sullivan Global GDP Growth Predictions
- GDP Growth Forecast, Selected Economies, Q1 2022–Q4 2023
- GDP Growth Rate, Selected Economies, 2022–2023
- Pharmaceutical Industry: Revenue Forecast by Segment, Global, 2022 and 2023
- Biologics: Revenue Forecast, Global, 2020–2027
- Pharmaceutical Industry: Revenue Forecast by Scenario, Global, 2020–2027
- Small Molecules: Revenue Forecast, Global, 2020–2027
- Pharmaceutical Industry: Revenue Forecast by Region, Global, 2023
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Outlook |
|---|---|
| Author | Surbhi Gupta |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Pharmaceutical Market Trends |
| Keyword 2 | Pharmaceutical Market Forecast |
| Keyword 3 | future trends in pharmaceutical industry |
| List of Charts and Figures | Pharmaceutical Industry: Implication for Key Stakeholders, Global, 2022–2027~ Pharmaceutical Industry: R&D Expenditure Forecast, Global, 2020–2027~ Pharmaceutical Industry: Drug Development Pipeline by Clinical Phase, Global, 2021–2022~ Pharmaceutical Industry: Therapeutic Segment Split, Global, 2022~ Pharmaceutical Industry: Therapeutic Segment Split, Global, 2027~ Comparison of January 2023 and August 2022 Frost & Sullivan Global GDP Growth Predictions~ GDP Growth Forecast, Selected Economies, Q1 2022–Q4 2023~ GDP Growth Rate, Selected Economies, 2022–2023~ Pharmaceutical Industry: Revenue Forecast by Segment, Global, 2022 and 2023~ Biologics: Revenue Forecast, Global, 2020–2027~ Pharmaceutical Industry: Revenue Forecast by Scenario, Global, 2020–2027~ Small Molecules: Revenue Forecast, Global, 2020–2027~ Pharmaceutical Industry: Revenue Forecast by Region, Global, 2023~ |
| Podcast | No |
| Predecessor | PCC8-01-00-00-00 |
| WIP Number | PE5D-01-00-00-00 |
